Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heidi Weiss

Showing results (21-30 of 54) with videos related to

Pageof 6
Sort By:
Nucleic Acids Research|July 30, 2016
NanoStringDiff: a novel statistical method for differential expression analysis based on NanoString nCounter dataHong Wang, Craig Horbinski, Hao Wu, et al.
Molecular Cancer Therapeutics|December 19, 2006
Cooperative action of tamoxifen and c-Src inhibition in preventing the growth of estrogen receptor-positive human breast cancer cellsMatthew H Herynk, Amanda R Beyer, Yukun Cui, et al.
Molecular Carcinogenesis|April 1, 2005
E1A-F is overexpressed early in human colorectal neoplasia and associated with cyclooxygenase-2 and matrix metalloproteinase-7William M Boedefeld, Richie Soong, Heidi Weiss, et al.
Future Oncology (London, England)|May 16, 2014
Impact of adding the multikinase inhibitor sorafenib to endocrine therapy in metastatic estrogen receptor-positive breast cancerSuleiman Massarweh, Jessica Moss, Chi Wang, et al.
Journal of the National Cancer Institute|May 2, 2007
Treatment of human epidermal growth factor receptor 2-overexpressing breast cancer xenografts with multiagent HER-targeted therapyGrazia Arpino, Carolina Gutierrez, Heidi Weiss, et al.
Gastroenterology|July 28, 2009
Visualizing hepatitis C virus infections in human liver by two-photon microscopyYuqiong Liang, Tuya Shilagard, Shu-Yuan Xiao, et al.
Cancer Research|February 5, 2008
Tamoxifen resistance in breast tumors is driven by growth factor receptor signaling with repression of classic estrogen receptor genomic functionSuleiman Massarweh, C Kent Osborne, Chad J Creighton, et al.
Redox Biology|July 6, 2019
Extracellular vesicle-mediated macrophage activation: An insight into the mechanism of thioredoxin-mediated immune activationChontida Yarana, Hannah Thompson, Luksana Chaiswing, et al.
Breast Cancer Research and Treatment|March 17, 2006
The growth hormone receptor antagonist pegvisomant blocks both mammary gland development and MCF-7 breast cancer xenograft growthJana Divisova, Isere Kuiatse, ZaWaunyka Lazard, et al.
Urology|June 19, 2007
Efficacy of selective estrogen receptor modulators in nude mice bearing human transitional cell carcinomaGuru Sonpavde, Norihiko Okuno, Heidi Weiss, et al.
Pageof 6

Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
Nucleic Acids Research|July 30, 2016
NanoStringDiff: a novel statistical method for differential expression analysis based on NanoString nCounter dataHong Wang, Craig Horbinski, Hao Wu, et al.
Molecular Cancer Therapeutics|December 19, 2006
Cooperative action of tamoxifen and c-Src inhibition in preventing the growth of estrogen receptor-positive human breast cancer cellsMatthew H Herynk, Amanda R Beyer, Yukun Cui, et al.
Molecular Carcinogenesis|April 1, 2005
E1A-F is overexpressed early in human colorectal neoplasia and associated with cyclooxygenase-2 and matrix metalloproteinase-7William M Boedefeld, Richie Soong, Heidi Weiss, et al.
Future Oncology (London, England)|May 16, 2014
Impact of adding the multikinase inhibitor sorafenib to endocrine therapy in metastatic estrogen receptor-positive breast cancerSuleiman Massarweh, Jessica Moss, Chi Wang, et al.
Journal of the National Cancer Institute|May 2, 2007
Treatment of human epidermal growth factor receptor 2-overexpressing breast cancer xenografts with multiagent HER-targeted therapyGrazia Arpino, Carolina Gutierrez, Heidi Weiss, et al.
Gastroenterology|July 28, 2009
Visualizing hepatitis C virus infections in human liver by two-photon microscopyYuqiong Liang, Tuya Shilagard, Shu-Yuan Xiao, et al.
Cancer Research|February 5, 2008
Tamoxifen resistance in breast tumors is driven by growth factor receptor signaling with repression of classic estrogen receptor genomic functionSuleiman Massarweh, C Kent Osborne, Chad J Creighton, et al.
Redox Biology|July 6, 2019
Extracellular vesicle-mediated macrophage activation: An insight into the mechanism of thioredoxin-mediated immune activationChontida Yarana, Hannah Thompson, Luksana Chaiswing, et al.
Breast Cancer Research and Treatment|March 17, 2006
The growth hormone receptor antagonist pegvisomant blocks both mammary gland development and MCF-7 breast cancer xenograft growthJana Divisova, Isere Kuiatse, ZaWaunyka Lazard, et al.
Urology|June 19, 2007
Efficacy of selective estrogen receptor modulators in nude mice bearing human transitional cell carcinomaGuru Sonpavde, Norihiko Okuno, Heidi Weiss, et al.
Pageof 6